RxDoctor Payments Data

Tara Kerr

Internal Medicine · Federal Way, WANPI 1780181867

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 40th percentile of 2,038 internal medicine providers in Washington.

See all internal medicine providers in Washington

Medicare billing

Part B allowed, 2024
$613,804
Medicare patients
634
Services billed
23,660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide19$44,284
MounjaroTirzepatide18$25,630
JardianceEmpagliflozin13$19,040
FarxigaDapagliflozin Propanediol11$17,361
EliquisApixaban12$9,910
Estradiol27$3,433
Omeprazole161$3,324
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$3,145
Atorvastatin Calcium319$2,597
Gabapentin137$2,357
Duloxetine Hcl73$2,306
Levothyroxine Sodium169$1,871
SynthroidLevothyroxine Sodium19$1,727
Fluoxetine Hcl40$1,635
Lisinopril203$1,577

Paid to pharmacies, not to this prescriber.

Other internal medicine in Federal Way

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →